Home NewsHansa’s kidney transplant drug succeeds in Phase 3 trial in US

Hansa’s kidney transplant drug succeeds in Phase 3 trial in US

by Endpoints News
0 comments
Hansa’s kidney transplant drug succeeds in phase 3 trial in

An im­mune an­ti­body-cleav­ing drug from Hansa Bio­phar­ma could soon make it eas­i­er for some pa­tients to get kid­ney trans­plants in the US.

The Swedish biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

news source

You may also like

Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.

Most Viewed Articles

Latest Articles

Copyright ©️ 2025 Daily Transplant News | All rights reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
Show/Hide Player
-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00